• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 5 of 100
A man walks next to a sign for the Roche Holding AG headquarters on April 11, 2025 in Basel, Switzerland. Before US President Donald Trump postponed a range of imminent tariffs, Switzerland was facing a daunting 31% levy on most Swiss goods to imported to the United States, a higher rate than would have been imposed on European Union countries. Such a tariff would've been high damaging to iconic Swiss industries like chocolate and watchmaking. The reprieve will provide breathing room for Swiss officials looking to negotiate a deal with the US, although Swiss goods will still face a 10% tariff in the meantime, and the fate of a potential separate tariff on pharmaceuticals is unknown.
Health
Swiss drugmaker Roche leans into Trump tariff formula with $50 billion promise to invest in U.S.
By Ryan HoggApril 22, 2025
Novo Nordisk slides on pressure from Lilly’s pill study
Retail
Novo Nordisk slides on pressure from Lilly’s pill study
By Marthe Fourcade and BloombergApril 22, 2025
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
Politics
Trump eyes new tariffs on semiconductors and pharmaceuticals as U.S. only makes 20% of world’s drugs and 0% of advanced logic chips
By Elaine Kurtenbach and The Associated PressApril 15, 2025
LArs Freurgaard Jorgensen and Ursula von der Leyen pictured among Danish business leaders in 2024.
Health
Europe’s pharma titans confront von der Leyen with threat to yank $113 billion from EU and relocate to U.S. as Trump plans ‘major’ tariffs
By Ryan HoggApril 9, 2025
The Ha'penny Bridge is a pedestrian bridge built in 1816 over the River Liffey in Dublin, Ireland.
Finance
Could Trump tariffs solve Ireland’s housing crisis?
By Ryan HoggApril 8, 2025
Stock market numbers are displayed on the floor of the New York Stock Exchange during morning trading on April 03, 2025 in New York City. (Photo: Michael M. Santiago/Getty Images)
Newsletters
How Trump’s import tariffs shocked tech stocks
By Andrew NuscaApril 4, 2025
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
Retail
Siemens to boost drug discoveries using AI through the $5.1 billion acquisition of U.S. software firm Dotmatics
By AFPApril 3, 2025
Recursion’s automated high throughput wet lab
Features
Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market
By Erika FryApril 3, 2025
Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said.
Leadership
GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
By Ryan HoggApril 2, 2025
Photo of Mark Cuban
Health
Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers
By Ani FreedmanApril 1, 2025
Katherine Stueland
Tech
As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company
By Andrew NuscaMarch 31, 2025
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
Finance
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
By AFPMarch 27, 2025
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
Tech
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
By Ryan HoggMarch 27, 2025
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
Tech
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By Ryan HoggMarch 25, 2025
AstraZeneca to buy cell therapy biotech for up to $1 billion
Tech
AstraZeneca to buy cell therapy biotech for up to $1 billion
By Ashleigh Furlong and BloombergMarch 17, 2025
1...
  • 3
  • 4
  • 5
  • 6
  • 7
...100
Most Popular
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Success
Philanthropy leader at Warren Buffett and Bill Gates’ Giving Pledge says children of billionaires are pushing them to give their wealth away fasterplaceholder alt text
By Preston ForeJune 27, 2026
Success
Elon Musk on MacKenzie Scott giving away $26 billion of her fortune: 'Sadly,' it makes the world a worse placeplaceholder alt text
By Sydney LakeJune 29, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.